Hims & Hers Deal History & Licensing Activity
Hims & Hers is a life sciences. Over the past three years, Hims & Hers has been involved in 1 licensing and acquisition transaction, with a primary focus on Peptides (2 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Peptides
Focus Area
Metabolic
Hims & Hers Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Hims & Hers in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Ozempic and Wegovy | Novo Nordisk | Peptides | Approved | collaboration | Mar 2026 |
Hims & Hers Pipeline Focus
Therapeutic areas and modalities where Hims & Hers is most active based on deal history and clinical trial data.
See How Your Asset Matches Hims & Hers's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Metabolic assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Metabolic Deal Benchmarks
Market sizing, deal terms, and competitive landscape for metabolic
Peptides Benchmarks
Upfront, milestone, and royalty benchmarks for peptides deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Hims & Hers Licensing & Deal Activity
Hims & Hers is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Hims & Hers ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Hims & Hers include Metabolic (2 deals and trials). In terms of modality, Hims & Hers has shown particular interest in peptides.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Hims & Hers and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Hims & Hers's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.